Page results
-
Professor Hough is a consultant heamatologist at UCLH. She has specialist expertise in the management of acute lymphoblastic leukaemia in teenagers and young adults, and the use of umbilical cord blood as an alternative source of haemopoietic stem cells.
-
Gastro-oesophageal reflux (GOR) is the effortless regurgitation of feeds/milk. It affects over 40% of babies.
-
Information about Lutetium-177 PSMA radionuclide therapy for metastatic or treatment-resistant prostate cancer
-
Professor Lunn's specialist clinical and research interests are in the inflammatory neuropathies, particularly Guillain-Barré syndrome, CIDP and paraproteinaemic neuropathies.
-
Dr Lynch is a consultant neurologist at the National Hospital for Neurology and Neurosurgery. He sees patients with all types of neurological disease in his general neurology clinics, and he has a particular interest in patients with inherited disorders of white matter, also called leukodystrophies
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using hybrid closed loop (HCL) systems.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
-
The Chartered Society of Physiotherapy (CSP) has announced that it will take industrial action on Thursday 26 January. As a result, its members that work at UCLH will be on strike on this day. CSP members will also be taking strike action on Thursday 9 Feb, though we are yet to hear if this will take place at UCLH.
-
The function to book blood test appointments will soon be transferred from MyCare to Swiftqueue. Target go-live date: 27th June
-
Professor David Choi is a consultant neurosurgeon. He sees patients with common conditions such as back and neck pain, disc problems, nerve root impingement, through to complex problems of spine and skull base tumours, endoscopic and craniocervical junction surgery.
File results
-
FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer
-
FOI/2024/0583 - National inpatient survey improvements/ night-time noise levels/ ward lighting/ mealtime support
-
FOI/2024/0584 - Immunology Hidradenitis Suppurativa (HS) treatments
-
FOI/2024/0586 - Subject Access Requests (SAR) and Freedom of Information (FOI) requests for 2023/24
-
FOI/2024/0587 - Colorectal cancer treatments
-
FOI/2024/0589 - SACT Cancer report/ Drug Patient Level Contract Monitoring (DrPLCM) report
-
FOI/2024/0594 - Implementation of Federated Data Platform (FDP) and procurement of data platforms
-
FOI/2024/0595 - Capital estate activity for 2020-2024
-
FOI/2024/0597 - Urothelial cancer treatments
-
FOI/2024/0605 - Finance software system/ installation and expiry of software